MP:0001554 | increased circulating free fatty acid level | "higher than normal levels of unesterified fatty acids in the blood" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:65146] |
Show
Allelic Composition: Mecp2tm1.1Vnar/Mecp2tm1.1Vnar Genetic Background: B6N.129-Mecp2tm1.1Vnar
|
MP:0002079 | increased circulating insulin level | "greater than normal levels of insulin in blood" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Mecp2tm1.1Vnar/Mecp2tm1.1Vnar Genetic Background: B6N.129-Mecp2tm1.1Vnar
|
MP:0003443 | increased circulating glycerol level | "higher than normal concentration of glycerol in the blood" [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Mecp2tm1.1Vnar/Mecp2tm1.1Vnar Genetic Background: B6N.129-Mecp2tm1.1Vnar
|
MP:0005292 | improved glucose tolerance | "better than the normal response to oral consumption or intravenous injection of specified amounts of glucose and indicative of insulin sensitivity; measured by determining whole blood or plasma sugar level in a fasting state before and after taking glucose at specified intervals" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Kcna1mceph/Kcna1mceph Genetic Background: BALB/cByJ-Kcna1mceph/J
|
MP:0005293 | impaired glucose tolerance | "less than the normal response to oral consumption or intravenous injection of specified amounts of glucose and indicative of insulin resistance; measured by determining whole blood or plasma sugar level in a fasting state before and after taking glucose at specified intervals" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Mecp2tm1.1Vnar/Mecp2tm1.1Vnar Genetic Background: B6N.129-Mecp2tm1.1Vnar
|
MP:0005317 | increased triglyceride level | "higher than normal concentration of triacylglycerols " [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Mecp2tm1.1Vnar/Mecp2tm1.1Vnar Genetic Background: B6N.129-Mecp2tm1.1Vnar
|
MP:0005331 | insulin resistance | "diminished effectiveness of insulin in lowering plasma glucose levels" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:84260, pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Mecp2tm1.1Vnar/Mecp2tm1.1Vnar Genetic Background: B6N.129-Mecp2tm1.1Vnar
|
MP:0005560 | decreased circulating glucose level | "less than the normal concentration in the blood of this major monosaccharide of the body; it is an important energy source" [RGD:Rat Genome Database submission, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Kcna1mceph/Kcna1mceph Genetic Background: BALB/cByJ-Kcna1mceph/J
|
MP:0008034 | enhanced lipolysis | "increase in the rate of the hydrolysis of fat into free fatty acids " [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Mecp2tm1.1Vnar/Mecp2tm1.1Vnar Genetic Background: B6N.129-Mecp2tm1.1Vnar
|
MP:0009356 | decreased liver triglyceride level | "lower than normal concentration of triacylglycerols in the liver" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Kcna1mceph/Kcna1mceph Genetic Background: BALB/cByJ-Kcna1mceph/J
|
MP:0020386 | adipose tissue inflammation | "local accumulation of fluid, plasma proteins, and leukocytes in adipose tissue" [MGI:anna, PMID:24662293, PMID:24695736, PMID:26629401] |
Show
Allelic Composition: Mecp2tm1.1Vnar/Mecp2tm1.1Vnar Genetic Background: B6N.129-Mecp2tm1.1Vnar
|